North Dakota committee supports bill for no-cost breast cancer diagnostic tests

March 18, 2025 | Industry and Business, Senate, Legislative, North Dakota


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

North Dakota committee supports bill for no-cost breast cancer diagnostic tests
A powerful call for change echoed through the North Dakota State Legislature on March 18, 2025, as advocates rallied for House Bill 1283, aimed at ensuring women have access to essential breast cancer diagnostic tests without financial burden. Mary, a breast cancer survivor, shared her emotional journey, highlighting the critical role of regular MRIs in her recovery. "Those diagnostic tests saved my life," she stated, urging lawmakers to support the bill that would eliminate out-of-pocket costs for necessary screenings.

The bill's supporters, including Ben Hansen from the American Cancer Society, emphasized the stark reality that 1 in 8 women will be diagnosed with breast cancer in their lifetime. Hansen pointed out the disparities in healthcare costs faced by women under similar insurance plans, stressing the need for parity in coverage for diagnostic imaging. "This bill is about catching up with advancements in medical technology," he said, advocating for early detection as a means to reduce long-term treatment costs.

Courtney Coble, Executive Director of the North Dakota Medical Association, also voiced her support, sharing her personal connection to breast cancer through her sister's experience. She underscored the importance of early detection, stating, "It's scary to think about how many lives breast cancer affects."

However, the bill faced opposition from the Greater North Dakota Chamber, which raised concerns about the financial implications for businesses. Andrea Fenig argued that the focus should be on making healthcare more affordable overall, rather than mandating specific coverage.

As the committee deliberates, the future of House Bill 1283 remains uncertain, but the testimonies from survivors and advocates highlight a pressing need for accessible breast cancer screenings. The outcome could significantly impact women's health and financial well-being across the state.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting

Sponsors

Proudly supported by sponsors who keep North Dakota articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI